Hyparillums A and B: polycyclic polyprenylated acylphloroglucinols from Hypericum patulum
Yulin DUAN,Zhengyi SHI,Fei SONG,Zhangrong HOU,Xiaosheng TAN,Yeting ZHANG,Xincai HAO,Gang CHEN,Changxing QI,Yonghui ZHANG
DOI: https://doi.org/10.1016/s1875-5364(24)60599-6
IF: 3.887
2024-03-28
Chinese Journal of Natural Medicines
Abstract:Hyparillums A ( 1 ) and B ( 2 ), two previously unidentified polycyclic polyprenylated acylphloroglucinols (PPAPs) with intricate architectures, were isolated from Hypericum patulum Thunb Hyparillum A was the first PPAP with eight-carbon rings based on an unprecedented 6/6/5/6/6/5/6/4 octocyclic system featuring a rare heptacyclo[10.8.1.1 1,10 .0 3,8 .0 8,21 .0 12,19 .0 14,17 ]docosane core. In contrast, hyparillum B featured a novel heptacyclic architecture (6/6/5/6/6/5/5) based on a hexacyclo[9.6.1.1 1,9 .0 3,7 .0 7,18 .0 11,16 ]nonadecane motif. Furthermore, hyparillums A and B demonstrated promising inhibitory effects on the proliferation of murine splenocytes stimulated by anti-CD3/anti-CD28 monoclonal antibodies and lipopolysaccharide, exhibiting half-maximal inhibitory concentration (IC 50 ) values ranging from 6.13 ± 0.86 to 12.69 ± 1.31 μmol·L −1 .
pharmacology & pharmacy,integrative & complementary medicine